PMVP — PMV Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for PMV Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	297	241	203	169	113
Prepaid Expenses
Total Other Current Assets
Total Current Assets	301	247	207	176	115
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.2	20.5	19	1.55	1.04
Long Term Investments
Other Long Term Assets
Total Assets	332	270	252	191	117
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	12.2	10.8	14	14.4	11.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	23	24.3	26.5	15.2	11.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	309	246	226	176	105
Total Liabilities & Shareholders' Equity	332	270	252	191	117
Total Common Shares Outstanding